Last Updated: 2026

SurModics

Rank#6829

Market Cap614.58M

CountryUnited States

Summary

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

History

SurModics, Inc. has a long history of incubating and commercializing medical innovations. Founded in 1979, SurModics has enjoyed decades of success by providing the know-how and custom biomedical engineering solutions to some of the most well-known medical device and diagnostic companies around the world. Now, as part of the Royal DSM family, we are striving to bring even more groundbreaking medical technologies to market.

Mission

At SurModics, our mission is to be the premier global partner for medical device and in vitro diagnostic manufacturers by providing custom biomedical engineering solutions to enable them to develop innovative and highly effective products that improve life.

Vision

Our Vision is to enable and empower our customers to address ever-changing clinical needs for improved global healthcare.

References

https://www.investing.com/equities/surmodics

https://www.comparably.com/companies/vision/mission

https://www.crunchbase.com/organization/surmodics-pharmaceuticals

https://finance.yahoo.com/quote/SRDX/

https://www.surmodics.com

https://sec.report/CIK/0000924717

Leadership team

Mr. Gary R. Maharaj (CEO, Pres & Director)

Mr. Timothy J. Arens (Sr. VP of Fin. & Information Technology and CFO)